Skip to content

ARCT ARCTURUS THERAPEUTICS HLDGS

Follow

COM (common), issuer CIK 1768224

Filings received so far for Q3 2026: 5 13F filers report a position in ARCT shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Green Alpha Advisors, LLC29,234$400K0.27%+2,14313F-HRTimeline
Versant Capital Management, Inc3,032$41.5K<0.01%+2,62713F-HRTimeline
GAMMA Investing LLC1,619$22.2K<0.01%-13113F-HRTimeline
Farther Finance Advisors, LLC789$10.8K<0.01%+23413F-HRTimeline
Marquette Asset Management, LLC49$671<0.01%new13F-HRTimeline

Events

  • FEDERATED HERMES, INC. and 4 other reporting persons reported 1,678,069 ARCT shares, 5.9% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-07. 0001623632-26-001546

    Accepted , ingested